Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Subscribe to see Firefly Neuroscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Firefly Neuroscience, Inc. is a healthtech company headquartered in Canada. It is publicly listed (AIFF) with a market capitalisation of $16M. Xcout tracks 18 named people at Firefly Neuroscience, Inc., including Greg Lipschitz (Chief Executive Officer & Director).
12 more named people on record for Firefly Neuroscience, Inc., with roles, board committees and tenure — see the full roster →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.